Read More

Pfizer Stock Breaks Out, What’s Next For The Vaccine Maker?

Pfizer Inc. (NYSE: PFE) shares are trading higher Monday after UBS analyst Colin Bristow upgraded it from a Neutral rating to a Buy rating and raised the price target from $52 to $60. Pfizer was up 3.83% at $54.80 at time of publication Monday afternoon.

PFE